The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Human Coagulation Factor VII Market Research Report 2024
Synopsis
Human Coagulation Factor VII is one of the proteins that cause blood to clot in the coagulation cascade. It is an enzyme of the serine protease class. It is sometimes used unlicensed in severe uncontrollable bleeding, although there have been safety concerns. A bio similar form of recombinant activated factor VII is also available, but does not play any considerable role in the market.
The global Human Coagulation Factor VII market was valued at US$ 2282.4 million in 2023 and is anticipated to reach US$ 4368 million by 2030, witnessing a CAGR of 9.6% during the forecast period 2024-2030.
Europe and North America are the largest region of Human Coagulation Factor VII, with about 40% market share respectively. NovoNordisk is the major manufacturer of industry.
This report aims to provide a comprehensive presentation of the global market for Human Coagulation Factor VII, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Coagulation Factor VII.
Report Scope
The Human Coagulation Factor VII market size, estimations, and forecasts are provided in terms of sales volume (K Mg) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Human Coagulation Factor VII market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Human Coagulation Factor VII manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
NovoNordisk
Segment by Type
Recombinant Factor VIII
Plasma-derived Factor VIII
Segment by Application
Hemophilia A
Spontanous / Trauma
Surgical
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Human Coagulation Factor VII manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Human Coagulation Factor VII in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Human Coagulation Factor VII is one of the proteins that cause blood to clot in the coagulation cascade. It is an enzyme of the serine protease class. It is sometimes used unlicensed in severe uncontrollable bleeding, although there have been safety concerns. A bio similar form of recombinant activated factor VII is also available, but does not play any considerable role in the market.
The global Human Coagulation Factor VII market was valued at US$ 2282.4 million in 2023 and is anticipated to reach US$ 4368 million by 2030, witnessing a CAGR of 9.6% during the forecast period 2024-2030.
Europe and North America are the largest region of Human Coagulation Factor VII, with about 40% market share respectively. NovoNordisk is the major manufacturer of industry.
This report aims to provide a comprehensive presentation of the global market for Human Coagulation Factor VII, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Coagulation Factor VII.
Report Scope
The Human Coagulation Factor VII market size, estimations, and forecasts are provided in terms of sales volume (K Mg) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Human Coagulation Factor VII market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Human Coagulation Factor VII manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
NovoNordisk
Segment by Type
Recombinant Factor VIII
Plasma-derived Factor VIII
Segment by Application
Hemophilia A
Spontanous / Trauma
Surgical
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Human Coagulation Factor VII manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Human Coagulation Factor VII in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Human Coagulation Factor VII Market Overview
1.1 Product Overview and Scope of Human Coagulation Factor VII
1.2 Human Coagulation Factor VII Segment by Type
1.2.1 Global Human Coagulation Factor VII Market Value Comparison by Type (2024-2030)
1.2.2 Recombinant Factor VIII
1.2.3 Plasma-derived Factor VIII
1.3 Human Coagulation Factor VII Segment by Application
1.3.1 Global Human Coagulation Factor VII Market Value by Application: (2024-2030)
1.3.2 Hemophilia A
1.3.3 Spontanous / Trauma
1.3.4 Surgical
1.3.5 Others
1.4 Global Human Coagulation Factor VII Market Size Estimates and Forecasts
1.4.1 Global Human Coagulation Factor VII Revenue 2019-2030
1.4.2 Global Human Coagulation Factor VII Sales 2019-2030
1.4.3 Global Human Coagulation Factor VII Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Human Coagulation Factor VII Market Competition by Manufacturers
2.1 Global Human Coagulation Factor VII Sales Market Share by Manufacturers (2019-2024)
2.2 Global Human Coagulation Factor VII Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Human Coagulation Factor VII Average Price by Manufacturers (2019-2024)
2.4 Global Human Coagulation Factor VII Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Human Coagulation Factor VII, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Human Coagulation Factor VII, Product Type & Application
2.7 Human Coagulation Factor VII Market Competitive Situation and Trends
2.7.1 Human Coagulation Factor VII Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Human Coagulation Factor VII Players Market Share by Revenue
2.7.3 Global Human Coagulation Factor VII Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Human Coagulation Factor VII Retrospective Market Scenario by Region
3.1 Global Human Coagulation Factor VII Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Human Coagulation Factor VII Global Human Coagulation Factor VII Sales by Region: 2019-2030
3.2.1 Global Human Coagulation Factor VII Sales by Region: 2019-2024
3.2.2 Global Human Coagulation Factor VII Sales by Region: 2025-2030
3.3 Global Human Coagulation Factor VII Global Human Coagulation Factor VII Revenue by Region: 2019-2030
3.3.1 Global Human Coagulation Factor VII Revenue by Region: 2019-2024
3.3.2 Global Human Coagulation Factor VII Revenue by Region: 2025-2030
3.4 North America Human Coagulation Factor VII Market Facts & Figures by Country
3.4.1 North America Human Coagulation Factor VII Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Human Coagulation Factor VII Sales by Country (2019-2030)
3.4.3 North America Human Coagulation Factor VII Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Human Coagulation Factor VII Market Facts & Figures by Country
3.5.1 Europe Human Coagulation Factor VII Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Human Coagulation Factor VII Sales by Country (2019-2030)
3.5.3 Europe Human Coagulation Factor VII Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Human Coagulation Factor VII Market Facts & Figures by Country
3.6.1 Asia Pacific Human Coagulation Factor VII Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Human Coagulation Factor VII Sales by Country (2019-2030)
3.6.3 Asia Pacific Human Coagulation Factor VII Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Human Coagulation Factor VII Market Facts & Figures by Country
3.7.1 Latin America Human Coagulation Factor VII Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Human Coagulation Factor VII Sales by Country (2019-2030)
3.7.3 Latin America Human Coagulation Factor VII Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Human Coagulation Factor VII Market Facts & Figures by Country
3.8.1 Middle East and Africa Human Coagulation Factor VII Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Human Coagulation Factor VII Sales by Country (2019-2030)
3.8.3 Middle East and Africa Human Coagulation Factor VII Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Human Coagulation Factor VII Sales by Type (2019-2030)
4.1.1 Global Human Coagulation Factor VII Sales by Type (2019-2024)
4.1.2 Global Human Coagulation Factor VII Sales by Type (2025-2030)
4.1.3 Global Human Coagulation Factor VII Sales Market Share by Type (2019-2030)
4.2 Global Human Coagulation Factor VII Revenue by Type (2019-2030)
4.2.1 Global Human Coagulation Factor VII Revenue by Type (2019-2024)
4.2.2 Global Human Coagulation Factor VII Revenue by Type (2025-2030)
4.2.3 Global Human Coagulation Factor VII Revenue Market Share by Type (2019-2030)
4.3 Global Human Coagulation Factor VII Price by Type (2019-2030)
5 Segment by Application
5.1 Global Human Coagulation Factor VII Sales by Application (2019-2030)
5.1.1 Global Human Coagulation Factor VII Sales by Application (2019-2024)
5.1.2 Global Human Coagulation Factor VII Sales by Application (2025-2030)
5.1.3 Global Human Coagulation Factor VII Sales Market Share by Application (2019-2030)
5.2 Global Human Coagulation Factor VII Revenue by Application (2019-2030)
5.2.1 Global Human Coagulation Factor VII Revenue by Application (2019-2024)
5.2.2 Global Human Coagulation Factor VII Revenue by Application (2025-2030)
5.2.3 Global Human Coagulation Factor VII Revenue Market Share by Application (2019-2030)
5.3 Global Human Coagulation Factor VII Price by Application (2019-2030)
6 Key Companies Profiled
6.1 NovoNordisk
6.1.1 NovoNordisk Corporation Information
6.1.2 NovoNordisk Description and Business Overview
6.1.3 NovoNordisk Human Coagulation Factor VII Sales, Revenue and Gross Margin (2019-2024)
6.1.4 NovoNordisk Human Coagulation Factor VII Product Portfolio
6.1.5 NovoNordisk Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Human Coagulation Factor VII Industry Chain Analysis
7.2 Human Coagulation Factor VII Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Human Coagulation Factor VII Production Mode & Process
7.4 Human Coagulation Factor VII Sales and Marketing
7.4.1 Human Coagulation Factor VII Sales Channels
7.4.2 Human Coagulation Factor VII Distributors
7.5 Human Coagulation Factor VII Customers
8 Human Coagulation Factor VII Market Dynamics
8.1 Human Coagulation Factor VII Industry Trends
8.2 Human Coagulation Factor VII Market Drivers
8.3 Human Coagulation Factor VII Market Challenges
8.4 Human Coagulation Factor VII Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
